BCAB vs MS · $5.9M cap vs P/E 20, $344.27B cap
Bioatla Inc (BCAB) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
MS does not have a complete income-statement cache yet.
BCAB currently screens at market cap $5.9M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the BCAB and MS stock pages for the full models.
Not investment advice.